Clinical Trial Update: Autologous Umbilical Cord Blood Transfusion for Preterm Neonates [Phase 1]

View source ↗

Summary

A Phase 1 autologous umbilical cord blood transfusion trial in preterm neonates has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Prematurity
• Intraventricular Hemorrhage
• Respiratory Distress Syndrome

Drugs mentioned

• Autologous Umbilical Cord Blood Transfusion

Snippet

Sponsor: Sahar M.A. Hassanein, MD | Conditions: Prematurity, Respiratory Distress Syndrome | Phase 1 | Status: WITHDRAWN